Related Experiment Video
Updated: Aug 12, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Myasthenia gravis: Frequently asked questions
1Staff, Neuromuscular Center, and Program Director, Neuromuscular Medicine Fellowship, Neurological Institute, Cleveland Clinic, Cleveland, OH; Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.
Myasthenia gravis is an autoimmune disorder affecting neuromuscular junctions, causing fatigable muscle weakness. Treatment is individualized, involving medications, immunotherapy, and surgery.
Area of Science:
- Neurology
- Immunology
Background:
- Myasthenia gravis is an autoimmune disorder impacting neuromuscular junction transmission.
- It is characterized by antibodies targeting the post-synaptic membrane.
- Clinical presentation includes fatigable skeletal muscle weakness, varying in severity and location.
Purpose of the Study:
- To provide an up-to-date, clinically relevant review of myasthenia gravis.
- To offer high-yield information in a question-and-answer format.
- To guide individualized treatment strategies for myasthenia gravis patients.
Main Methods:
- Literature review utilizing a question-and-answer format.
- Synthesis of current clinical knowledge on myasthenia gravis.
- Focus on practical, evidence-based information for clinicians.
Main Results:
- Myasthenia gravis results from antibodies disrupting neuromuscular transmission.
- Pyridostigmine, immunotherapy, and thymectomy are primary treatment modalities.
- Treatment decisions are personalized based on disease factors.
Conclusions:
- Effective management of myasthenia gravis requires understanding its autoimmune basis and varied clinical course.
- Individualized treatment plans are crucial for optimal patient outcomes.
- This review serves as a valuable resource for clinicians managing myasthenia gravis.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Muscle Contraction
Myocarditis IV: Nursing Management

